ResultsIQ › Latest results › Anthem Biosciences Limited
Anthem Biosciences Limited Q1 FY26 results deck summary
NSE: ANTHEM · BSE: 544449
Results deck of 13 Aug 2025, summarised by AI from the filing.
Q1FY26 revenue from operations ₹5,402 mn, up 59.5% YoY, with EBITDA ₹2,143 mn and PAT ₹1,358 mn.
Key takeaways
- Revenue Q1FY26 revenue from operations ₹5,402 mn (Q1FY25: ₹3,386 mn, +59.5%).
- EBITDA Q1FY26 EBITDA ₹2,143 mn (Q1FY25: ₹1,404 mn, +52.7%); EBITDA margin 38.1% (Q1FY25: 39.2%).
- PAT Q1FY26 PAT ₹1,358 mn (Q1FY25: ₹824 mn, +64.8%); PAT margin 24.1%.
- Net cash Net cash ₹7,848 mn as of June 30, 2025 (Mar 31, 2025: ₹6,242 mn).
Anthem Biosciences Limited Q1 FY27 results
As filed: Revenue ₹418 cr (−23% year on year), EBITDA ₹151 cr (−21% year on year), PAT ₹120 cr (−12% year on year), EBITDA margin 36.0% (+63 bps).
The Q1 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹583 cr, EBITDA ₹267 cr, PAT ₹212 cr, EBITDA margin 45.8%. Not scored. No result for the same quarter last year. Share price after the results: +1.4% in 30 days (Nifty 500: +3.0%).
- Q3 FY26: Revenue ₹417 cr, EBITDA ₹163 cr, PAT ₹112 cr, EBITDA margin 39.1%. Not scored. No result for the same quarter last year. Share price after the results: +21.1% in 30 days (Nifty 500: +2.8%).
- Q2 FY26: Revenue ₹552 cr, EBITDA ₹225 cr, PAT ₹198 cr, EBITDA margin 40.8%. Not scored. No result for the same quarter last year. Share price after the results: −6.8% in 30 days (Nifty 500: 0.0%).
- Q1 FY26: Revenue ₹538 cr, EBITDA ₹196 cr, PAT ₹148 cr, EBITDA margin 36.4%. Not scored. No result for the same quarter last year. Share price after the results: +10.4% in 30 days (Nifty 500: +2.2%).
Past price moves after results do not indicate future moves. Not a recommendation.
Anthem Biosciences Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (22 Jul 2026), Results deck (21 Jul 2026), Results deck (21 Jul 2026), Results press release (21 Jul 2026), Results press release (21 Jul 2026)
- Q4 FY26: Earnings call (20 May 2026), Results deck (19 May 2026)
- Q3 FY26: Earnings call (5 Feb 2026), Results deck (5 Feb 2026), Results press release (5 Feb 2026), Results press release (5 Feb 2026), Results press release (5 Feb 2026)
- Q2 FY26: Earnings call (10 Nov 2025), Results deck (8 Nov 2025), Results press release (8 Nov 2025)
- Q1 FY26: Earnings call (14 Aug 2025), Results deck (13 Aug 2025), Results press release (13 Aug 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.